REGENERON PHARMAC.DL-001/ US75886F1075 /
| 2024-12-23 7:57:05 AM | Chg. -7.6000 | Volume | Bid8:18:01 AM | Ask8:18:01 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 674.8000EUR | -1.11% | - Turnover: - |
671.8000Bid Size: 17 | 678.2000Ask Size: 17 | 73.96 bill.EUR | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 37.05 USD | -8.54% |
| EPS Diluted: | 34.77 USD | -9.03% |
| Revenues per Share: | 121.52 USD | 7.32% |
| Book Value per Share: | 240.62 USD | 14.14% |
| Cash Flow per Share: | 42.56 USD | -8.76% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 13,117.20 USD | 7.76% |
| Net Income: | 3,953.60 USD | -8.87% |
| Operating Cash Flow: | 4,594.00 USD | - |
| Cash and Cash Equivalents: | 2,730.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 18.94 | 23.71 |
| P/S Ratio: | 5.78 | 7.23 |
| P/BV ratio: | 2.92 | 3.65 |
| P/CF Ratio: | 16.49 | 20.64 |
| PEG: | -2.22 | -2.78 |
| Earnings Yield: | 5.28% | 4.22% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 73.96 bill. EUR | 85.87 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 108.07 mill. | |
Profitability
| Gross Profit Margin: | 86.16% |
| EBIT Margin: | 30.85% |
| Net Profit Margin: | 30.14% |
| Return on Equity: | 15.22% |
| Return on Assets: | 11.95% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.80% |
| Liquidity II / Quick Ratio: | 2.45% |
| Liquidity III / Current Ratio: | 5.69% |
| Debt / Equity Ratio: | 0.10% |
| Dynam. Debt / Equity Ratio: | 154.70% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
